載入...
IV/IT hUC-MSCs Infusion in RRMS and NMO: A 10-Year Follow-Up Study
Background: Stem cell transplantation is emerging as a potential therapeutic strategy in several autoimmune diseases. However, the safety and feasibility of long-term combined intravenous (IV) and intrathecal (IT) administration of hUC-MSCs in relapse remitting multiple sclerosis (RRMS) and neuromye...
Na minha lista:
| 發表在: | Front Neurol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7506071/ https://ncbi.nlm.nih.gov/pubmed/33013641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00967 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|